BRIEF-FDA grants Merrimack fast track designation for Seribantumab (mm-121) in non-small cell lung cancer By: Reuters: Company News July 06, 2016 at 08:11 AM EDT * FDA Grants Merrimack fast track designation for Seribantumab (Mm-121) in non-small cell lung cancer Read More >>